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HONG KONG  
 
MAJOR PROFESSOR:  Dr. Barbara Hagler 
 
 The introduction of clinical Positron Emission Tomography (PET) in oncology in 
the 1990s has substantially changed the management of patients with cancer and 
become one of the diagnostic modalities with the fastest growth worldwide (Buck et al., 
2010).  The major hurdle delaying the proliferation of PET was partly due to its high 
initial investment and insufficient third-party reimbursement (Keppler & Conti, 2001).  
Hong Kong, a region with about half the economic strength of Germany, was able to 
sustain a higher ratio of PET-CT scanners than that of Germany.  Through the study of 
the PET utilization in Hong Kong, this research is to (i) explore the factors contributing 
to this phenomenon; and (ii) find out if those factors are applicable to other developing 
countries. 
The key factors found contributed to a higher ratio of PET-CT scanners in Hong 
Kong were: 1) medical expertise in a regionally profound disease; 2) the direct payment 
culture which enables an economically efficient and a cost-effective operation; 3) the 
influx of patients from neighboring countries; and 4) the reputation of its medical 
services.  Applying these factors, citizens in developing countries were able to have 
access to the latest and expensive medical technology. 
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CHAPTER 1 
INTRODUCTION 
 Cancer is the second leading cause of death in the United States (U.S.), just 
behind heart disease, according to the latest data provided by the Centers for Disease 
Control and Prevention (CDC, 2009).  The risk, in this country, of being diagnosed with 
cancer is approximately one in two for men, and one in three for women; the risk of 
dying from cancer is approximately one in four for men, and one in five for women 
(American Cancer Society, 2010a).  Another publication furnished by the American 
Cancer Society in 2011, Global Cancer Facts & Figures 2nd Edition, illustrated the 
global picture of cancer statistics in 2008 and the near future trend: 
Worldwide, one in eight deaths is due to cancer; cancer causes more deaths 
than AIDS, tuberculosis, and malaria combined.  When countries are grouped 
according to economic development, cancer is the leading cause of death in 
developed countries and the second leading cause of death in developing 
countries (following heart diseases).  According to recent World Health 
Organization (WHO) projections, cancer will have replaced ischemic heart 
disease as the overall leading cause of death worldwide in 2010. (p. 1) 
 Those statistical results shown above from both the U.S. and the world revealed 
that cancer has become a prominent disease in the public health of human history.  
Every year, it profoundly affects not only tens of millions of people who are diagnosed 
with cancer, but also their families and friends. 
 Since the signing of the National Cancer Act in 1971 (OGCR), the United States 
has devoted a tremendous amount of resources to cancer research and the investment 
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is making a difference now.  The U.S. cancer death rate began to drop in 1992; the 
combined incidence rate of all new cancers has been falling since 1999; and cancer 
patients live longer and enjoy a better quality of life than those of the previous 
generation.  However, the incidence rates of skin cancer, kidney cancer, thyroid cancer, 
and liver cancer are rising.  As this nation’s population grows and ages, more people 
are expected to get cancer during their lifetime (National Cancer Institute, 2010). 
 In order to treat cancer effectively, early detection is the key.  The earlier a 
cancer is detected, the better the chances that treatment will work and the better the 
survival rate (American Cancer Society, 2010b; National Cancer Institute, 2011b).  A 
system has been developed to describe the status of a person’s cancer condition.  It is 
called cancer staging. 
Staging describes the severity of a person’s cancer based on the extent of the 
original (primary) tumor and whether or not cancer has spread in the body. 
Staging is important for several reasons: 
• Staging helps the doctor plan the appropriate treatment.  
• The stage can be used to estimate the person’s prognosis.  
• Knowing the stage is important in identifying clinical trials that may be 
suitable for a particular patient.  
• Staging helps health care providers and researchers exchange 
information about patients; it also gives them a common terminology for 
evaluating the results of clinical trials and comparing the results of 
different trials. (National Cancer Institute, 2011a, Cancer Staging, para. 1) 
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 It is obvious that the staging process is very important because treatment and 
outlook for recovery depends on the stage of a cancer.  For early cancer, surgery may 
be the best option.  For more advanced cancer, however, surgery may not be useful.  
Other treatment regiments such as chemotherapy or radiation therapy may be more 
appropriate (American Cancer Society, 2011b). 
 Due to its capability of earlier and more precise diagnosis, molecular imaging has 
become a popular term of medical diagnosis in recent years (Peterson & Manning, 
2009).  Positron Emission Tomography (PET), the most common molecular imaging 
modality, is very sensitive in the detection of biological abnormalities in neurological 
disorders with no CT or MRI anatomic changes, or even before symptoms (Phelps, 
2000). 
 Since the Center for Medicare and Medicaid of the United States started 
reimbursement for the clinical PET utilization in oncology in the 1990s, and especially 
after the invention of PET-CT in 2000, PET has substantially changed the management 
of patients with cancer and become one of the diagnostic modalities with the fastest 
growth worldwide (Buck et al., 2010).  
 Representing one of the largest growth medical modalities in the world, 
approximately 2,000 PET-CT scanners were installed in the United States, 70 were 
installed in Germany (Buck et al., 2010), and 12 were installed in Hong Kong (J. 
Cheung., personal communication, October 27, 2010).   
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Table 1 
Demographic, Economic, and PET-CT Data in the United States, Germany, and Hong 
Kong (2009) 
Nation Population 
(million) 
Number of 
PET-CT 
Ratio 
(per million) 
GDP per 
Capita (US$) 
United States 307 2,000 6.5 47,240 
Germany 82 70 1.2 42,560 
Hong Kong 7 12 1.7 23,900 
Note. Adapted from Buck et al. (2010), Census & Statistics Department of Hong Kong 
SAR (2010a), and World Bank (2010). 
 
 
Statement of the Problem 
 As shown in Table 1, Hong Kong supported a higher PET-CT scanner per 
population ratio (1.7 vs.1.2) than that of Germany with only 56% of its gross domestic 
product (GDP) per capita. In fact, Germany is a member of the G7 nations which are 
considered the first tier of economic strength countries in the world.  How can Hong 
Kong, a region with about half the economic strength of Germany, sustain a higher ratio 
of PET-CT scanners than Germany?  According to Keppler and Conti (2001), the major 
hurdle in utilizing PET is the financial burden associated with the expensive equipment 
and running cost.  The average cost of setting up a PET center with the 
radiopharmaceutical production capacity ranged from US$5 million (low-cost scanner) 
to over US$6.2 million (high-end scanner) in the U.S.  The running cost ranged from 
US$1.6 million to over US$2.6 million per year.  If this advanced PET technology can 
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be utilized in a way that countries with less economic strength are able to afford, it will 
have a tremendous health benefit to their cancer patients.  Therefore, the purpose of 
this research study is to (i) explore the factors contributing to the PET utilization 
development in Hong Kong; and (ii) find out if those factors are applicable to other 
developing countries.  
 
Research Questions 
 This study looked at the history of PET utilization development as well as 
investigated the medical and socioeconomic environment in Hong Kong.  The following 
questions served as structural guiding steps for the direction of this research. 
 Question 1.  What is the clinical advantage of PET and PET-CT in the detection 
and monitoring of cancer patients compared to conventional diagnostic imaging 
modalities? 
 Question 2.  How has the medical environment in Hong Kong affected PET 
utilization development? 
 Question 3.  How has the socioeconomic environment in Hong Kong affected 
PET utilization development? 
 
Significance of the Problem 
 Due to the adoption of western lifestyles in developing countries, such as 
smoking, high fat and high cholesterol diet, lack of physical exercise, being overweight, 
use of birth control pills, and use of alcohol, cancers related to these risk factors, such 
as lung, breast, and colorectal cancers will continue to rise (American Cancer Society, 
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2011a).  In developing countries, public funding available for the healthcare sector is 
not as abundant as funding in economically developed countries (World Health 
Organization, 2011).  If the experience of PET utilization in Hong Kong can provide 
significant insights for a sustainable model of utilizing expansive advanced medical 
technology with less financial burden on the society, it will significantly benefit the vast 
number of people in those economically developing countries.  
 
Limitations and Delimitations 
 As the application of PET technology in developing countries only occurred in the 
last 10 years, limited prior research is available.  This research looked into the financial 
aspect of the currently functioning medical facilities, both in the public and private 
sectors of Hong Kong.  The willingness of those medical facilities to provide business 
information was a limitation.  Therefore, information came from information-rich 
persons who have witnessed and also participated in the entire development cycle of 
PET utilization in Hong Kong for the last 10 years.  The point of view of these finite 
experts contributed to the limited scope of this study.  Also, manpower, financial, and 
time resources were limitations for this study as well. 
 Many of the examples and literature presented in the following sections focus on 
cancer and molecular imaging, primarily because that is the area in which the author is 
profoundly involved. 
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Definition of Terms 
Clinical advantage of PET: The clinical advantage of PET expresses in terms of 
its higher diagnostic sensitivity and specificity compared with conventional diagnostic 
imaging modalities, which include the diagnosis, staging, monitoring treatment, and 
detecting recurrence of a variety of tumors (Alavi & Reivich, 2002).   
Computed Tomography (CT): Computed Tomography is a diagnostic imaging 
procedure that uses X-rays to produce 2-dimensional and 3-dimensional cross-sectional 
images or "slices" of areas of the body.  Characteristics of the internal structure of an 
object such as dimensions, shape, internal defects, and density can be found from CT 
images (Computed tomography, 2011).  
Conventional diagnostic imaging: Conventional diagnostic imaging is a general 
term referring to the imaging methods of computed tomography (CT), magnetic 
resonance imaging (MRI), sonography (US), and Radiography (X-ray) (Adams, Baum, 
Stuckensen, Bitter, & Hör, 1998). 
 Developing countries: The economy of countries are divided according to 2010 
gross national income (GNI) per capita using the World Bank Atlas method: low income, 
$1,005 or less; lower middle income, $1,006 - $3,975; upper middle income, $3,976 - 
$12,275; and high income, $12,276 or more. The World Bank classifies all low- and 
middle-income countries as developing economies.  However, the use of this term is 
convenient.  The levels of development may vary widely within so-called developing 
countries (World Bank, 2012). 
Diagnostic sensitivity: The conditional probability that a person having a disease 
will be correctly identified by a clinical test, i.e., the number of true positive results 
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divided by the total number with the disease (which is the sum of the numbers of true 
positive plus false negative results) (Mosby's Medical Dictionary, 2009a).  
Diagnostic specificity: The conditional probability that a person not having a 
disease will be correctly identified by a clinical test, i.e., the number of true negative 
results divided by the total number of those without the disease (which is the sum of the 
numbers of true negative plus false positive results) (Mosby's Medical Dictionary, 
2009b).  
Magnetic Resonance Imaging (MRI): Magnetic Resonance Imaging is an 
advanced imaging method using a magnetic field, radio waves and a computer system 
to produce 3-D cross-sectional images of organs and internal structures in the body.  
Because the signal detected by an MRI machine varies depending on the water content 
and local magnetic properties of a particular area of the body, different tissues or 
substances can be distinguished from one another in the study image.  For example, 
an MRI exam of a joint can provide detailed images of ligaments and cartilage, which 
are not visible using other study types.  In some cases, a magnetically active material 
(called a contrast agent) is used to show internal structures or abnormalities more 
clearly (Magnetic Resonance Imaging, 2011). 
Metastasis: By moving through the bloodstream or lymphatic system, cancer 
cells can spread from the primary site to lymph nodes or to other organs, where they 
may form new tumors.  The spread of cancer is called metastasis (National Cancer 
Institute, 2011a). 
Ultrasound (sonography): Ultrasound imaging uses high-frequency sound waves 
to produce pictures of the inside of the body.  Because ultrasound images are captured 
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in real-time, they can show movement of the body's internal organs as well as blood 
flowing through blood vessels.  Ultrasound exams do not use ionizing radiation as used 
in x-rays (Medical Imaging, 2011). 
X-ray (Radiography): Radiography can be thought of as “X-ray photography”.  It 
is the visualization of the internal parts of the body (object) by passing an X-ray beam 
through some section of a patient’s body to form a static image.  The images that are 
formed are recorded either on film or some form of digital media (Medical X-ray, 2011).  
 
  
 The Society of Nuclear Medicine 
imaging: “Molecular imaging is the visualization, characterization, and measurement of 
biological processes at the molecular or cellular levels in 
systems” (Mankoff, 2007, p. 18N).
Conventional diagnostic
(CT), Magnetic Resonance Imaging (MRI), X
through the visualization of the presence, location
common molecular imaging modality
at the molecular or cellular level before anatomical changes of the tissues
al., 2009). 
 
 
X-ray 
Figure 1.  Anatomy vs Function
functional (physiological) imaging.
 
 
 
 
 
CHAPTER 2 
REVIEW OF LITERATURE 
Molecular Imaging 
has adopted an official definition for 
humans and other living 
   
 imaging modalities, such as Computed Tomography 
-ray, and ultrasound, show the pathologies 
, and extent.  PET as the
, in the contrary, can detect pathological changes 
 
 
CT MRI 
: X-ray, CT, and MRI are anatomical imaging. PET is 
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 (Peterson et 
 
PET 
11 
 
 
 
As shown in Figure 1, conventional diagnostic imaging (X-ray, CT, MRI, etc.) 
looks through the anatomy (structure) of the body to examine if there is any pathological 
abnormality (disease).  In contrast, only abnormal functionality (physiology) of the body 
will show up as a distinct visualization — “hot” spot (increased uptake) on a PET scan 
image (as pointed by the arrow in Figure 1).  The rest of the normal tissues and organs 
will show as a light and faint background.  This distinct feature of visualization of 
functional abnormality in the cellular and molecular level enables molecular imaging to 
detect hidden cancers in an early stage before any signs of anatomical change (Mankoff, 
2007; Peterson et al., 2009). 
PET whole body imaging in cancer provides the means to (i) identify early 
disease, (ii) differentiate benign from malignant lesions, (iii) examine all organs 
for metastases, and (iv) determine therapeutic effectiveness.  Diagnostic 
accuracy of PET is 8-43% higher than conventional procedures and changes 
treatment in 20-40% of the patients … in lung and colorectal cancers, melanoma, 
and lymphoma, with similar findings in breast, ovarian, head and neck, and renal 
cancers. (Phelps, 2000, p. 9226) 
 
Principle of 18F-FDG PET 
 Today, the most commonly used PET tracer for clinical molecular imaging in 
oncology is 18F-FDG.  18F-FDG is an analog of glucose labeled with a radioactive 
positron emitter.  The definition of cancer, in liberal terms, is rapid cell growth and 
replication without control.  Therefore, cancer cells’ metabolic rate is two to 10 times 
more than that of normal cells.  “18F-FDG PET exploits the typically increased glucose 
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metabolism of tumor tissues, compared with surrounding normal tissues” (Peterson et 
al., 2009, p. 156).   
 In a typical 18F-FDG PET examination, the radioactive 18F-FDG is injected 
intravenously.  Through a PET scanner, the radioactive signals emitted by 18F-FDG are 
transformed into a three-dimensional image of a human body, and those cancer tissues 
are lit up as hot spots for visualization.   This is the principle behind an 18F-FDG PET 
(Peterson et al., 2009; Phelps, 2000). 
 
 
 
 
Figure 2.  PET images of colorectal cancer. 
 
 As illustrated in Figure 2, the radioactive sugar (glucose) injected into the body 
was absorbed by the cancer cells in a much higher ratio.  They showed up as hot spots 
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(a very large and intensive primary tumor in the rectum, and multiple liver metastases) 
on a three-dimensional PET image compared to surrounding normal tissues, making 
them the easy targets for disease identification. 
 
The Development of PET-CT 
 PET-CT, which captured the award of “Time Magazine's Medical Invention of the 
Year 2000” (Jaroff, 2000), is a technological breakthrough which integrates two 
separate diagnostic modalities, anatomical imaging (CT), and molecular and 
physiological imaging (PET), into one device and procedure.  This combination results 
in high-resolution anatomical images accurately fused with functional data and the 
further increase of sensitivity and specificity of cancer imaging (Townsend, 2008).  The 
imaging time per patient is reduced by 60% as well (Sitt & Ho, 2002).  Using today’s 
most advanced model, Biograph m-CT, a whole body PET-CT scan can be done in five 
minutes, a 90% reduction in imaging time compared to the first generation of dedicated 
PET scanner (Siemens, 2010). 
 In Figure 3, the top row is PET images; the middle row is PET-CT fusion images; 
and the bottom row is CT images.  Those bright spots on the top row of the PET 
images showed the multiple and extensive metastases of cancer cells in both lungs, 
which provide the diagnosis of the patient.  However, the locations of those diseased 
lymph nodes were not precise because there was no distinct anatomical reference 
(Townsend, 2008).  The bottom row of CT images demonstrated a clear anatomical 
structure of the lung, which serves as a road map of the human body.   Combining the 
top row of PET images and the bottom row of CT images, the middle row of the PET-CT 
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fusion image not only provided the patient’s diagnosis but also the exact location of 
those metastatic lymph nodes. 
 
 
 
PET Image  
 
 
 
PET-CT Fusion Image  
 
 
CT Image  
Figure 3.  Illustration of PET-CT fusion images. 
 
 Figure 3 illustrates how the functional data (PET) and the anatomical data (CT) of 
two imaging modalities combined together increase the sensitivity and specificity of 
cancer imaging. 
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Diagnostic Effectiveness of PET and PET-CT in Oncology 
 
18F-FDG PET allows the detection of malignant tumors based on increased 
glucose uptake (metabolism).  In a typical PET imaging, the scan range will cover from 
the base of the skull down to the middle of the thigh.  Basically, most of the internal 
organs will be covered by a single image to determine if the patient has concealed 
cancer.  As cancer cells are generally highly metabolically active and divide rapidly, 
they consume two to 10 times more glucose than normal cells (Peterson et al., 2009). 
Therefore, they appear as “hot spots” in the PET scan, which make them the easy 
target for tumor identification. 
 As an example, approximately 40% of the diagnosed solitary pulmonary lung 
nodule cases are malignant (Bury et al., 1996).  PET scan has the ability to distinguish 
between malignant and benign nodules with a 90%+ accuracy.  According to Buck et 
al., “18F-FDG PET has a sensitivity of 89%-100%, a specificity of 69%-100%, and an 
accuracy of 89%-96%” (2010, p. 8). 
 
Evaluation of Response to Treatment 
 According to the standard Response Evaluation Criteria in Solid Tumors used by 
the World Health Organization (WHO, 2007), the response to treatment is measured 
and estimated by the volume reduction of the tumor.  However, there is a time lag of 
between three to 12 months from the time of the tumor responding to therapy to the 
reduction of the tumor volume (Buck et al., 2010).  In contrast, PET measures the 
glucose metabolism as an indicator of effective therapy because cancer that is 
successfully treated will no longer be metabolically active (Buck et al., 2010).  
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Therefore, PET scan can show the effectiveness, at a much earlier time, of surgery, 
chemotherapy, and radiotherapy in the treatment of cancer. 
 
18F-FDG PET-CT to Aid in the Planning of Radiotherapy 
The planning of radiotherapy has traditionally relied heavily on CT using the 
Response Evaluation Criteria in Solid Tumors, which measures the physical volume of 
the target volume.  The use of metabolic information from PET leads to the 
measurement of biologic target volume, which can alter the radiation field by increasing 
or reducing the target volume.  Increasingly, 18F-FDG PET-CT is being incorporated 
into the treatment-planning process and promises to improve the ability to confidently 
identify regions of disease (Ford, Herman, Yorke, & Wahl, 2009). 
For example, a positive response from previous treatment may show a shrinking 
biologic target volume on PET images compared to the same physical tumor size on CT 
images.  Consequently, by applying the PET data, the radiation field can be reduced 
and the radiation dose to neighboring tissues can be minimized as well.   
As mentioned by Buck et al., “overall survival of patients receiving PET-based 
radiation treatment planning was significantly higher than that of patients treated without 
the use of PET” (2010, p. 10).  The role of 18F-FDG PET is expected to continue to 
evolve and provide additional benefits to radiation oncology. 
  
Difficulties of 18F-FDG PET for Liver Cancer 
 Liver cancer is one of the top three causes of cancer death in many Asian 
countries, including Hong Kong, Taiwan, Singapore, and Japan (Ho, Chen, Yeung, & 
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Cheng, 2007).  Although 18F-FDG is very sensitive in the detection of many cancers, it 
is known that 18F-FDG PET has a 40-50% false negative rate in the detection of liver 
cancer (Chen, Ho, & Feng, 2004; Ho, Yu, & Yeung, 2003).  
 Unlike Asian countries, liver cancer is a rare disease in the United States.  
However, an upward trend of the disease has been shown recently because of the 
increasing frequency of hepatitis C viral infection and the influx of Asian immigrants (Ho 
et al., 2003).  Accurate PET imaging protocol for liver cancers did not exist at the time 
when PET was first introduced into Hong Kong by the Hong Kong Sanatorium & 
Hospital (HKSH) in 1999 (Chen, Ho, & Feng, 2004; Ho, Yu, & Yeung, 2003).  In order 
to resolve this issue, practitioners and research scientists at HKSH explored the 
utilization of other PET tracers and previously published research in the detection of 
liver cancer.  Details of how to solve this issue of liver cancer detection with PET will be 
elaborated on more in chapter 4 of this paper. 
 
PET Utilization in Alzheimer’s Disease 
 PET application has gone beyond oncology.  One of the major fields of research 
utilizing PET technology is in Alzheimer’s disease.  Due to the aging population, more 
and more people are potentially affected by this disease (Alzheimer’s, 2010). 
 By 2030, 20% of all Americans, about 70 million people, will pass their 65th 
birthday (Cavanaugh, & Cavanaugh, 2010, back cover).  “Life expectancy rose from 49 
years in 1900 to 68.1 years in 1950 and then 77.8 years in 2004, a gain of almost 30 
years in just over a century in the United States” (Himes & Meyer, 2010, p. 2).  
Alzheimer’s disease (AD), the most common cause of dementia, will affect more and 
18 
 
 
 
more people.  In fact, it is estimated that as many as 5.2 million people in the United 
States have AD (National Institute on Aging, 2010a).  This number is expected to grow 
over the next 50 years as the population ages and life span increases (National Institute 
on Aging, 2010b).   
 In Australia, the number of people affected by dementia is expected to triple from 
the current 257,300 (1% population) in 2010 to 1,130,700 (2.8% of the projected 
total population) by 2050….  AD currently costs the Australian health system 
A$3.2 billion a year in direct costs, and is expected to be A$6 billion within 5 
years.  If interventions were able to delay the onset of the disease by even 5 
months, there would be a 5% reduction in the cost of AD to the Australian 
economy; if we could delay onset by 5 years, we would halve the costs [2]. (Ellis 
et al., 2010, p. 291)  
 In Hong Kong, the 65 and over age group rose from 12% in 2006 to 12.9% in 
2009 (Census & Statistics Department, 2010b).  The number of people affected by AD 
is consistent with the increase in life expectancy and population aging of the worldwide 
trend.  AD affects all walks of lives. An outstanding scholar of Hong Kong and the 2009 
Nobel Prize winner in Physics, Dr. Charles K. Kao, is unfortunately afflicted by this 
disease and could not personally receive his honor in Norway. 
 It is a worldwide effort to address this AD issue from all fronts.  Through 
research, more is being learned about how Alzheimer's affects the brain.  The 
Australian Imaging Biomarkers and Lifestyle (AIBL) Flagship Study of Aging, utilizing 
the Pittsburgh compound B (11C-PiB) PET and MRI, has completed its first 18-month 
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follow-up project in collaboration with the Alzheimer’s Disease Neuroimaging Initiative 
(ADNI) worldwide effort (Ellis et al., 2010). 
 
Training Needs for Physicians Entering PET Modality 
Experienced and competent physicians who can provide PET-CT analysis 
service are in great demand considering the rapid expansion of PET modality. Alavi and 
Reivich stated,  
 Training in diagnostic radiology and conventional nuclear medicine is inadequate 
for the interpretation of these complex PET studies.  It is becoming quite clear 
that acquiring optimal skills to interpret FDG-PET images will require at least 6 
months of full-time training in this discipline.  Fellowships for a period of 1 to 2 
weeks as a certificate of competence are unjustifiable and in fact will be a 
disservice to the medical community. (2002, p. 2) 
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CHAPTER 3 
METHODS AND PROCEDURES 
 
Introduction 
 The purpose of this research study is to (i) explore the factors contributing to the 
PET utilization development in Hong Kong; and (ii) find out if those factors are 
applicable to other developing countries. 
The research questions used as the key concern of the study were: 
Question 1.  What is the clinical advantage of PET and PET-CT in the detection and 
monitoring of cancer patients compared to conventional diagnostic imaging modalities? 
Question 2.  How has the medical environment in Hong Kong affected PET utilization 
development? 
Question 3.  How has the socioeconomic environment in Hong Kong affected PET 
utilization development? 
   
Research Design 
The goal of this research was to explore and understand the current practice of 
PET imaging modality in Hong Kong, and to evaluate if these factors are applicable to 
other developing countries. This type of study is characterized as exploratory and 
explanatory.  It is, according to McMillan and Schumacher (2010), “To identify 
relationships influencing the phenomena” (p. 324).  To achieve this objective, the 
researcher utilized a qualitative approach based mainly on direct observation of the 
common practice related to this field complemented with quantitative data analysis.   
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 A study with an emergent design was conducted to examine and understand 
what factors were contributing to this phenomenon.  Three major approaches were 
utilized in this qualitative research:  Ethnography—in-depth description and 
interpretation of cultural patterns and meanings within a specified culture or social 
group; Case Study—in-depth analysis of single entity; and Phenomenology Study—
description and interpretation of the experiences of participants regarding particular 
events in order to understand the meaning ascribed to those events (McMillan & 
Schumacher, 2010).   
 To begin explaining this complex phenomenon, the researcher collected data 
from the medical and socioeconomic environment in Hong Kong. Secondly, the author 
used purposeful sampling including individuals, groups, documents, reports, and sites to 
retrieve information-rich cases for an in-depth study.  It should be noted that the 
researcher is himself one of the pioneers of the PET imaging modality practice who 
introduced this new technology to Hong Kong.  Per communications with research 
institution’s representative, IRB approval was not required for this study (R. Sinha., 
personal communication, November 30, 2011). 
 
Sampling Strategy 
 The purpose of the sampling strategy was to search for information-rich key 
informants, events, or sites to study.  The sampling strategy included convenient 
sampling and sampling by case type.  The sampling by case type consisted of an 
extreme case and a typical case.  A leader of PET medical imaging modality in Hong 
Kong was chosen as the extreme case.  One typical case from a private health sector 
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was selected to reflect the practical situation.  Due to the reluctance of releasing 
sensitive operational data, only one private PET center other than the leading PET 
center was willing to release operational data on conditions of anonymity.   
 
Research Methodology and Data Collection 
 First, a quantitative approach was utilized in answering research question #1 
about the clinical advantage of PET and PET-CT in the detection and monitoring of 
cancer patients, because quantitative data were obtainable and available for this issue. 
 For research questions #2 and #3, three aspects of the qualitative approach were 
utilized in this research; in-depth description and interpretation of cultural patterns; in-
depth analysis of a single entity; and description and interpretation of the experiences of 
participants regarding particular events.  Due to the small amount of written information 
about the PET cost data survey, circuitous and indirect supporting data were utilized to 
illustrate the factors influencing the proliferation of PET in Hong Kong.  In order to 
estimate the socioeconomic impact on PET development, a cost structure analysis with 
a breakdown of the operational budget of PET facility was assessed.  Details of the 
assumptions and estimates for this cost analysis are given in Chapter 4. 
As the application of PET technology in developing countries only occurred in the 
last 10 years, limited prior research is available for correlations.  The investigator 
collected information directly from the source, i.e. directly observed and interacted with 
the settings, participants, and documents studied.  All of those activities essentially 
formed the data collection instrument.  As the researcher was an active PET 
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practitioner, his active experience with the PET development in Hong Kong was the 
backbone of this research. 
 
Inductive Data Analysis 
 All data collected was synthesized inductively to generate findings.  Through 
inductive reasoning, these seemingly unconnected and perhaps too extensive findings 
generated conclusions to answer the research questions, and ultimately, provided a 
new prospective to the statement of the problem.  This analysis was developed using a 
bottom up approach according to the detailed particulars.  It opened up a new way of 
understanding PET utilization in a developing region, as contrasted with the medical 
environment of developed nations such as Germany and the U.S. 
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CHAPTER 4 
 
FINDINGS AND DATA ANALYSIS 
 
Introduction 
 The purpose of this research study is to (i) explore the factors contributing to the 
PET utilization development in Hong Kong; and (ii) find out if those factors are 
applicable to other developing countries. 
The research questions used as the key concern of the study were: 
Question 1.  What is the clinical advantage of PET and PET-CT in the detection and 
monitoring of cancer patients compared to conventional diagnostic imaging modalities? 
Question 2.  How has the medical environment in Hong Kong affected PET utilization 
development? 
Question 3.  How has the socioeconomic environment in Hong Kong affected PET 
utilization development? 
 
Research Question Results 
Research Question 1 
What is the clinical advantage of PET and PET-CT in the detection and 
monitoring of cancer patients compared to conventional diagnostic imaging modalities? 
Referring to the principle of PET modality illustrated in Chapter 2, PET imaging 
distinguishes changes in cancer cells at the cellular level by detecting differences in 
their metabolic activity compared with normal cells.  This contrasts with conventional 
diagnostic modalities such as CT, MRI, ultrasound, and X-ray, which detect structural 
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change. The research study of Jadvar, Alavi and Gambhir (2009) indicated the clinical 
diagnostic advantage of 18F-FDG PET for lung, breast, and colon cancers. 
Table 2 is a summary of 39 meta-analysis results by Gould et al. (2003) 
comparing the diagnostic accuracy of CT and 18F-FDG PET for mediastinal staging in 
patients with non-small cell lung cancer, and it demonstrated that PET was more 
accurate than CT.   
Table 2 
PET and CT for Mediastinal Staging in Lung Cancer 
Variable Median Sensitivity (IQR) Median Specificity (IQR) 
CT  
(1119 patients in 
23 studies) 
 
61 (50-71) 
 
79 (66-89) 
PET  
(1959 patients in 
32 studies) 
 
85 (67-91) 
 
90 (82-96) 
Note: IQR = interquartile range 
Source:  Gould, M. K., Kuschner, W. G., Rydzak, C. E., Maclean, C. C., Demas, A. 
N., …Owens, D. K. (2003). Test performance of positron emission tomography and 
computed tomography for mediastinal staging in patients with non-small cell lung cancer. 
Annals of Internal Medicine, 139, 879-892. 
 
 
As approximately 40% of solitary pulmonary lung nodule cases are malignant 
(Bury et al., 1996), 18F-FDG PET has the ability to distinguish between malignant and 
benign nodules with “a sensitivity of 89%-100%, a specificity of 69%-100%, and an 
accuracy of 89%-96%”, as stated by Buck et al. (2010, p. 8). 
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Table 3 
Sensitivity and Specificity of PET and CDI in Detection of Colorectal Cancer Recurrence 
 Year Sensitivity 
(CDI) 
Sensitivity 
(PET) 
Specificity 
(CDI) 
Specificity 
(PET) 
Beets et al.24 1994 8/15 (53) 14/15 (93) 18/20 (90) 19/20 (95) 
Schiepers et al.35 1995 30/47 (65) 45/47 (96) 25/25(72) 34/35 (97) 
Keogan et al.36 1997 11/13 (84) 12/13 (92) 2/5 (40) 5/5 (100) 
Ogunbiyi et al.37 1997 - 19/21 (90) - 26/26 (100) 
Valk et al.28 1999 21/31 (68) 30/31 (97) 76/84 (90) 81/84 (96) 
Flamen et al.38 1999 24/33 (73) 31/33 (94) 62/70 (89) 69/70 (99) 
Whiteford et al.31 
Staib et al. 30 
Lonneux et al.34 
2000 
2000 
2002 
22/31 (71) 
- 
11/15 (73) 
28/31 (90) 
22/23 (96) 
15/15 (100) 
33/39 (85) 
- 
61/63 (96) 
35/39 (92) 
74/77 (96) 
62/63 (98) 
CDI = conventional diagnostic imaging. PET = Positron Emission Tomography 
Data are numbers with percentages in parentheses. 
 
Source:  Watson, A. J., Lolohea, S., Robertson, G. M., & Frizelle, F. A. (2006). The role 
of positron emission tomography in the management of recurrent colorectal cancer: A 
review. Diseases of the Colon & Rectum, 50, 102-114. doi: 10.1007/s10350-006-0735-7 
 
 
Table 3 is a statistical summary of a literature research study by Watson, 
Lolohea, Robertson, and Frizelle (2006) that reviewed the role of PET in the 
assessment of patients with suspected recurrent colorectal cancer.  The result of this 
study, covering patient data from 1994 to 2002, further confirmed PET is more sensitive 
and more specific than conventional diagnostic imaging for metastatic disease and local 
recurrence of colorectal cancer respectively.   
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Conclusion.  As stated by Phelps (2000), one of the PET inventors, “Diagnostic 
accuracy of PET is 8-43% higher than conventional procedures and changes treatment 
in 20-40% of the patients … in lung and colorectal cancers, melanoma, and lymphoma, 
with similar findings in breast, ovarian, head and neck, and renal cancers” (p. 9226). 
The emergence of PET-CT hybrid scanners resulted in high-resolution 
anatomical images accurately fused with functional data, and this new technology 
further increased the sensitivity and specificity of cancer imaging with PET modality 
(Townsend, 2008). 
 
Research Question 2 
How has the medical environment in Hong Kong affected PET utilization 
development? 
According to the latest information confirmed by Mok of the Radiation Board 
(division of the Department of Health and a radiation governing body in Hong Kong, 
Appendix A), there were a total of 12 PET-CT scanners in Hong Kong in 2011.  Four 
were at public hospitals (three were operational and one was under installation), and the 
other eight were in the private sector.  The private sector actually leads the clinical PET 
development in Hong Kong.  According to the information of establishment date 
provided by the Radiation Board (Appendix A), the first, second, and the third PET 
scanners were set up by three private entities in 1998, 2001, and 2002 respectively. 
Four years after the introduction of PET technology to Hong Kong, the first public PET 
facility was finally launched into service in Queen Elizabeth Hospital in 2003.  Since the 
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first PET scanner became operational in 1999, there have been two private PET centers 
were shut down.  
Nevertheless, the private sector still has a dominant capacity of a two to one ratio 
compared with the public sector today.  Looking back at the introduction of PET 
technology, it went through numerous roadblocks to gain the confidence and 
acceptance of medical professionals as well as cancer patients (HKSH, 2009). One of 
the major hurdles was related to a locally profound cancer type – liver cancer which was 
difficult to diagnosis using 18F-FDG PET alone (Chen, Ho, & Feng, 2004; Ho, Yu, & 
Yeung, 2003). 
Through an in-depth case study analysis of liver cancer, a unique clinical PET 
expertise was established by the leader of a PET facility in Hong Kong (Ho et al., 2007).  
Difficulties of 18F-FDG PET for liver cancer.  Liver cancer is one of the top 
three causes of cancer death in many Asian countries, including China, Taiwan, 
Singapore, and Japan (Ho et al., 2007).  Although 18F-FDG is very sensitive in the 
detection of many cancers, it is known that 18F-FDG PET has a 40-50% false negative 
rate in the detection of liver cancer (Chen et al., 2004; Ho et al., 2003).  
 Unlike in Asian countries, liver cancer is a rare disease in the United States.  
There has only been an upward trend of the disease recently because of the increasing 
frequency of the hepatitis C viral infection and the influx of Asian immigrants (Ho et al., 
2003).  Accurate PET imaging protocol for liver cancers did not exist at the time when 
PET was first introduced into Hong Kong by the Hong Kong Sanatorium & Hospital 
(HKSH) in 1999 (HKSH, 2009).  In order to resolve this issue, practitioners and 
29 
 
 
 
research scientists at HKSH explored the utilization of other PET tracers and previously 
published research in the detection of liver cancer.   
   
 
  
Figure 4.  The well-differentiated HCCs accumulate 11C-Acetate without 18F-FDG 
uptake. 
 
 
 
 From 2000 to 2002, through a series of tracer kinetic modeling, dynamic 
analysis, and numerous trials of imaging protocols, a significantly sensitive and specific 
protocol of  11C-Acetate PET was established in complementing the deficiency of 18F-
FDG in PET imaging of liver masses (Chen, Ho, & Feng, 2003; Chen et al., 2004; Chen, 
Ho, & Feng, 2006; Ho et al., 2003).   
Ho et al. (2007) further explored and found that the pattern of tracer uptake by 
the tumors was correlated with tumor cellular differentiation.  The study showed the 
well-differentiated liver cancer tumors preferentially accumulated 11C-Acetate (illustrated 
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in Figure. 4), whereas the poorly differentiated tumors tended to accumulate 18F-FDG 
(illustrated in Figure. 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  The poorly differentiated HCC tumors tended to be prone to accumulate 18F-
FDG without 11C-Acetate accumulation. 
 
 
 
 
 The research result and the dual-tracer imaging protocol of 11C-Acetate and 18F-
FDG PET published by Ho et al. (2007) were well-received and recognized by the 
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molecular imaging community.  It was presented as the cover article for the 2007 issue 
of the Journal of Nuclear Medicine—the leading medical journal in the field of nuclear 
medicine and molecular imaging.  Today, liver cancer is no longer a blank space within 
the spectrum of PET diagnosis. 
Collaborated PET service.  As previously mentioned, liver cancer is one of the 
top three causes of cancer death in many Asian countries.  According to the clinical 
data of The Department of Surgery at The University of Hong Kong (HKU) (2010), tumor 
resection and transplant are the most effective cures for this disease.  For patients with 
unresectable tumors, the advent of radiofrequency ablation and transarterial oily 
chemoembolization offers an effective treatment alternative.  The Department of 
Surgery at HKU is the largest liver cancer referral center in the region.  Its liver 
transplant service developed into the largest program in China and Southeast Asia, and 
it is renowned internationally for its excellence in clinical service and research.  By the 
end of October 2008, a total of 659 liver transplants had been performed with one-year, 
three-year, and five-year survival rates of 92%, 87%, and 84% respectively, and the 
mortality rate of hepatic resection for liver cancer was approaching 0% (Department of 
Surgery, 2010). 
Liver cancer patients from around the world go to Hong Kong to seek treatment 
because of its specialty in dealing with this disease.  Through collaborations with HKU 
and other liver cancer oncologists, HKSH (2009) fully utilized the dual-tracer PET 
protocols in the aid of diagnosis as well as therapeutic response monitoring of these 
patients.  Due to the strong demand, patients may need to wait between a few days to 
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one week to schedule their exams, as HKSH is the only center providing 11C-Acetate 
and 18F-FDG dual tracer PET-CT service. 
 
Research Question 3 
How has the socioeconomic environment in Hong Kong affected PET utilization 
development? 
Due to the confidentiality concern of their operating costs, only two of the PET 
centers in Hong Kong were willing to provide their service volume figures and an 
estimate of patient demographic data.  The rest of the groups were reluctant and did 
not respond to the request from this study.  In order to provide an approximation of the 
cost of a PET facility, a simplified breakdown of the operational budget analysis was 
constructed along with a breakeven throughput estimate. 
The major cost components of a PET facility were narrowed down to its PET-CT 
scanner, the real estate to house the facility, salaries and benefits associated with the 
clinical staff, medical supplies, utilities, and administrative costs to simplify this cost 
analysis.   According to the study of Keppler and Conti, the breakeven throughput for a 
high-end PET scanner was in the range of 6.75 procedures per day based on the 
financial data collected from PET centers in the U.S. (2001).  As all the existing 
facilities in Hong Kong were equipped with PET-CT scanners (Radiation Board, 
appendix B) which are considered high-end PET scanners (Keppler & Conti, 2001), this 
breakeven point estimate would be a good reference when applying this cost analysis.  
The first item on the cost list is the PET-CT scanner.  As those scanners are 
mainly manufactured either by Siemens (with manufacturing plants both in the U.S. and 
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Germany) and General Electric (with manufacturing plants mainly in the U.S.), these 
would be an additional overseas premium and a higher freight charge when these 
scanners were purchased by the medical centers in Hong Kong.  Therefore, the end-
users in Hong Kong would be required to pay a higher cost than their counterparts in 
the U.S. or Germany.  That translated into a higher upfront setup cost of the medical 
equipment in Hong Kong. 
 
Table 4 
Global Office Occupancy Costs  
Market 
(Ranked in December 2010) 
Class A/Prime Space 
(US$ per square foot) 
1. Hong Kong 191.97 
2. London – West End 133.02 
14. New York, NY – Midtown Manhattan 65.04 
24. Washington, DC 53.59 
29. Frankfurt 50.21 
Note:  Adopted from Colliers International (2011), Global office real estate review. 
 
The second expansive item on the list is the real estate housing the PET facility. 
According to a recent property survey, illustrated in Table 4, by Colliers (2011), Hong 
Kong was ranked the number one city with the highest occupancy cost in the world 
(US$191.97/square foot).  New York City (Midtown Manhattan), the highest ranking city 
from the U.S., came in #14 (US$65.04/square foot).  The second highest ranking city 
from the U.S. was Washington, DC (US$53.59/square foot), which was rated as #24. 
The highest ranking city from Germany was Frankfurt, which was rated as a distant #29 
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(US$50.21/square foot).  Overall, the cost of space in Hong Kong was three times 
more expensive than that in the U.S. and Germany. 
The third item on the cost list is the cost of professional staff.  A salary survey 
conducted by the Nuclear Medicine Technology Certification Board in 2006 identified 
the salary range for a PET technologist in the U.S. was from US$40,000 to US$97,700, 
with a median value of US$62,868 (2007).  Compared to data retrieved from the 
Master Pay Scale of the Civil Service Bureau in Hong Kong (2011), the salary level of 
the same technologist position was from US$46,151 to US$92,608.  These two sets of 
data from the U.S. and Hong Kong respectively, therefore, indicated a comparable 
salary range for the PET clinical staff from these two regions of the world.  
An assumption was made that the PET clinical staff cost in Germany would fall 
into a similar range of the U.S. because the GDP per capita of these two countries were 
similar (World Bank, 2010). 
The last few items for comparison were medical supplies, utility cost, and 
administrative cost.  Although the PET facilities in Hong Kong needed to import all their 
medical supplies from abroad, and hence might incur higher costs than its counterparts 
in the U.S. and Germany, the researcher made a simplified assumption and assumed 
those costs would fall into a similar range within those regions. 
Using the financial data derived from the U.S. and Germany as an average 
standard, the costs of setting up and operating a PET facility in Hong Kong was 
compared against those standards to arrive at a qualitative comparison.  Table 5 is the 
consolidation summary of the data listed in the previous paragraphs. 
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Table 5 
A Simplified Cost Analysis of PET-CT Facility 
 U.S. Germany Hong Kong 
Cost of PET-CT Scanner average average higher 
Cost of Space average average 3 x higher 
Cost of Professional Staff average average average 
Other Costs (medical supplies, 
utilities, and administrative 
cost) 
average average average 
 
 
According to Keppler and Conti (2001), the scanner and space costs were the 
dominant capital expenditures, making up over 80% of total costs of a PET facility.  For 
this reason, it is clear to conclude from Table 5 that the total cost of setting up and 
operating a PET center in Hong Kong would be much higher than for its counterparts in 
the U.S. and Germany.  As the breakeven point for a high-end PET scanner was in the 
range of 6.75 procedures per day based on the financial data in the U.S. (Keppler et al., 
2001), PET centers in Hong Kong would require a procedure number higher than the 
6.75 in order to breakeven.  However, the majority of PET centers in Hong Kong 
performed six to eight procedures a day (Anonymous, personal communication, 
October 29, 2010), which would probably fall short of the breakeven point based on the 
financial viability calculation from Keppler et al. (2009).  
Excluding the extreme case of a PET center leader in Hong Kong, which 
performed scanning on 25 to 27 patients a day on its two PET scanners (M. Yeung., 
personal communication, October 27, 2010), the majority of the PET centers in Hong 
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Kong have been operational for more than three years.  If a PET facility was not able to 
produce positive net income in more than three years, its operation would probably not 
be sustainable.  According to information confirmed by the Radiation Board (Appendix 
A), two private PET centers were closed in the last few years in Hong Kong.  These 
two centers did not last more than two years (J. Cheung., personal communication, 
October 27, 2010; October 9, 2011).  Therefore, the researcher would make an 
assumption that the existing PET centers with more than three years of operational 
history were financially viable.   
If this viable operation assumption of the researcher is valid for the majority of 
PET centers in Hong Kong, how can those centers sustain a financially viable operation 
with a substantially higher capital expenditure and a lower procedure number per day 
than the breakeven point? 
In order to answer this question, an approach of in-depth description and 
interpretation of cultural patterns, an ethnography, was utilized to explore the possible 
answers. 
Direct payment culture.  According to the information from Buck et al. (2010), 
the costs of PET examination ranged between approximately $885 and $1,474 in 
Germany, and $1,030 to $2,109 in the United Kingdom.  According to two research 
studies completed in the early 2000s, the cost of PET examination in the US ranged 
approximately from $1,600 to $2,986 (Berger, Gould, & Barnett 2003; Keppler & Conti, 
2001).  In Hong Kong, the cost range was approximately between $900 and $2,179 (M. 
Yeung., personal communication, October 26, 2010).  Based on the data shown in 
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these research studies, the cost of obtaining a PET scan was in a similar range among 
European countries, the U.S., and Hong Kong.  
Hong Kong is considered to be a direct payment culture as compared to its 
counterparts of the US and Europe.  The cost of a PET examination is paid out directly 
from a patient’s own pocket in most of the cases in Hong Kong.  In contrast, costs of 
PET examination in the US and Europe are reimbursed by insurance companies, 
Medicare, or other social medicine systems (Benjamin, 1999; Biersack, 2009).  In Hong 
Kong, the common payment methods for medical providers are cash, credit cards such 
as Visa and MasterCard, and checks, as shown on the lists of medical providers from 
the local US Consulate (US Consulate Hong Kong, 2011).  For patients who have 
medical insurance coverage, the common practice is that patients will settle the medical 
bills with their medical providers first, and then the insurance companies will reimburse 
the medical costs to their clients after the insurance claims are approved.  That is 
equivalent to 100% reimbursement of the medical system in the United States, which is 
an incomprehensible level.   
Benjamin (1999) stated that numerous HMOs have made a hasty withdrawal 
from the Medicare market, citing increased costs and inadequate federal 
reimbursement.  Biersack (2009) pointed out that the PET-CT utilization development 
was hampered by the reimbursement issues in Germany as well.   
Appendix B holds a collection of the medical claim forms used by major 
insurance companies in Hong Kong.  One of the distinct requirements on all of these 
forms is to furnish medical or hospital payment receipts showing the charges for the 
treatment received.  This is another evidence of the direct payment culture. 
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As the imaging charge is settled between patients and the facility at the same 
time that the PET service is performed, the most important issues of manpower savings 
were outlined in the following list: 
1. Sending bills to insurance providers or reimbursement agencies 
2. Keeping track of the correct reimbursement amount and following up on any 
overdue payment 
3. Updating the service billing coding 
4. Fulfilling the ongoing updates of regulatory requirements such as the Centers 
for Medicare and Medicaid Services in order to be eligible for reimbursement 
The removal of the entire insurance reimbursement department, which is a 
common division within any medical institution in the U.S. and in Germany (Benjamin, 
1999; Biersack, 2009), provides tremendous savings toward the operation of a PET 
facility.  Furthermore, this direct payment practice effectively eradicates the issue of 
unpaid or underpaid bills from service providers, and achieves a solid accounting status 
equivalent to 100% reimbursement. 
By eliminating the reimbursement burden and the middle layer of insurance cost 
with the direct payment culture, PET centers in Hong Kong are able to operate in a 
more cost-effective and economically efficient way than their counterparts in Europe 
and the United States. 
Another prospect of a qualitative approach was to describe and interpret a 
sudden phenomenal event of the influx of patients into Hong Kong. 
Influx of patients.  For many years, Hong Kong has been a medical center for 
overseas Chinese because of its heritage link and high medical standards compared to 
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the neighboring Southeast Asian countries (Hokari, 1996).  Since the signing of the 
Mainland and Hong Kong Closer Economic Partnership Arrangement (CEPA) in 2003, 
people from China can travel to Hong Kong with fewer restrictions (2003).  One of the 
purposes of Mainland Chinese traveling to Hong Kong is to seek medical services 
because they trust the ethical standards and the professionalism displayed by 
healthcare professionals during the 2003 Severe Acute Respiratory Syndrome (SARS) 
outbreak (Lee, 2003).  Many patients are angry and tired of the unethical practices of 
their healthcare providers in China, such as (i) ordering high cost but unnecessary 
diagnostic services for a higher profit, (ii) prescribing overpriced medications for a 
higher profit, and (iii) reports of physicians not giving patients the proper treatment, thus 
causing unnecessary deaths and suffering (Ho, 1995).  
In addition to the devotion and self-sacrifice of medical and healthcare staff 
exhibited during the SARS outbreak (Lee, 2003), all 13 private hospitals in Hong Kong 
are accredited either by the Trent Accreditation Board from the United Kingdom, or by 
the Australia Council on Healthcare Standards (ACHS) from Australia (The Hong Kong 
Private Hospitals Association, 2011).  Some of these medical institutes are accredited 
by both accreditation organizations. The Trent Accreditation Board is an assessment 
scheme to support the development, integration, and assessment of organizational 
standards in the United Kingdom for small to medium size hospitals (Trent Accreditation 
Scheme, 2011).   The Australia Council on Healthcare Standards (ACHS) is Australia's 
leading health care assessment and accreditation provider (ACHS, 2011).  Due to the 
history of 154 years of British colonial rule, Hong Kong private hospitals are trying to 
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attach with those widely recognized standards within the developed commonwealth 
countries to set themselves apart by providing an international standard of care.  
 Highly qualified and dedicated medical professionals combined with the state of 
the art medical equipment and an international recognizable standard of care attracts 
patients from Mainland China to seek medical services in Hong Kong. 
 
 
 
 
Figure 6.  Crude Birth Rate (CBR) and Crude Death Rate (CDR), 1981 – 2010. 
 
Notes: The mortality and birth statistics are based on number of "registered" deaths and 
births.  
 
Source: Department of Health, The Government of Hong Kong SAR. (2010). Crude birth 
rate (CBR) and crude death rate (CDR), 1981 – 2009. Retrieved from 
http://www.chp.gov.hk/en/data/4/10/27/112.html 
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The obvious example of this influx of patient from Mainland China is the reverse 
trend of the birth rate in Hong Kong.  According to the Hong Kong Department of 
Health (2010), the birth rate has decreased from 16.8 per 1,000 population in 1981 to 
7.1 in 2002, and leveled off in 2003. However, the birth rate has begun to show a 
reverse trend since 2004, the first year CEPA became effective. It then reached a 
significant height of 12.5 in 2010, a 76.1 % jump in just six years, and kept growing.  
This birth rate figure indicates that approximately 50% of the newborn babies in 
Hong Kong currently are coming from Mainland China. This unprecedented 
phenomenon prompted the Hospital Authority of Hong Kong (the governing body of all 
public hospitals in Hong Kong) to set up a separate admission procedure for pregnant 
mothers from Mainland China in order to maintain an adequate maternity service for its 
local citizens (Hospital Authority, 2010). 
Another source of the patient influx is the expatriates from foreign companies.  
Yang (2010) stated that between 1980 and 2007 China approved a total of 632,298 
foreign-funded enterprises, and used US$766.655 billion in foreign investment.  As the 
global economy is shifting to the East, more and more foreign companies are either 
setting up new offices or expanding their existing operations in China and Hong Kong.  
When those expatriates seek medical services, they will go to Hong Kong simply 
because they have confidence in physicians with U.S. government recognized 
qualifications to practice in the specialties and those doctors are sufficiently competent 
in the English language to provide services to English-speaking clients (US Consulate 
Hong Kong, 2011).  Hong Kong, given its geographic proximity to China, its bilingual 
culture (English and Chinese), as well as a well-established pool of medical 
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professionals certified in the United States, is a natural and convenient hub to 
accommodate an expatriate’s medical needs. 
Although there are no official or direct statistics showing how many patients from 
abroad are currently seeking PET services in Hong Kong, a personal survey from the 
author showed that there was a range of 8% to 12% of patients who were non-Hong 
Kong citizens (M. Yeung., personal communication, October 27, 2010; Anonymous, 
personal communication, October 29, 2010).  This tentative influx of patient 
percentages translated into about 15 extra patients for the leading PET center as well 
as about four extra patients for the average PET centers in Hong Kong in a week. 
 
The Applicability of PET Utilization Experience to Developing Countries  
 After exploring the factors contributing to the PET utilization development in 
Hong Kong, the author determined if those same factors were applicable to other 
developing countries.  As mentioned in previous paragraphs, the major factors 
contributing to a higher ratio of PET-CT scanners in Hong Kong are: 
1) medical expertise in a regionally profound disease 
2) the direct payment culture which enables an economically efficient and a cost-
effective operation 
3) the influx of patients from neighboring countries 
4) the reputation of its medical services  
As factors #1 and # 4 can be closely related and complementary to each other, 
these two criteria will be discussed in a later section of this chapter.  The applicability of 
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factors #2 and #3 of PET utilization development experience in Hong Kong to other 
developing countries will be illustrated first. 
Factor #2 - The direct payment method.  The direct payment method can be 
readily applied to other developing countries if they wish to do so in order to boost an 
economically efficient and a cost-effective operation.  By eliminating the reimbursement 
burden from the public social medical system, the private health management 
organization, and the middle layer of insurance cost, PET centers are able to operate in 
a more cost-effective and economically efficient way. 
Factor #3 - An influx of paying patients.  The goal is to create an influx of 
paying patients to supplement the local medical demand.   
As a matter of fact, the major hurdle in utilizing PET is the financial burden 
associated with the costly equipment.  According to Keppler and Conti (2001), the 
average cost of setting up a PET center with the radiopharmaceutical production 
capacity ranged from $5 million (low-cost scanner) to over $6.2 million (high-end 
scanner) in the U.S.  The running cost ranged from $1.6 million to over $2.6 million per 
year.  In order to make the service viable, the PET facility required a range from 3.45 to 
6.75 procedures per day.   
The advantage of the developing countries are their low property values and low 
wages for physicians, nurses, and other healthcare providers such as Costa Rica, India, 
Malaysia, Mexico, Philippines, Thailand, and similar countries.  Those countries are 
able to provide the same medical procedures at a much lower cost (Turner, 2010).   
Table 6 shows the cost of performing a similar medical procedure in India ranges 
from the lowest of 5.6% to highest of 21.2%, from 6.3% to 27.9% in Thailand, and from 
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7.8% to 32.5% in Singapore, compared to the cost in the U.S.  The average cost level 
is about 13.4% for India (the mean of 5.6% and 21.2%), 17.1% for Thailand (the mean 
of 6.3% and 27.9%), and 20.2% for Singapore (the mean of 7.8% and 32.5%) of the 
cost in the U.S. (York, 2008). 
 
Table 6 
Comparative Costs of Medical Procedures by Country 
 
Procedure 
 
U.S. 
 
India 
 
Thailand 
 
Singapore 
 
Heart bypass 
 
$130,000 
 
$10,000 
 
$11,000 
 
$18,500 
 
Heart valve 
   replacement 
 
$160,000 
 
$9,000 
 
$10,000 
 
$12,500 
 
Angioplasty 
 
$57,000 
 
$11,000 
 
$13,000 
 
$13,000 
 
Hip replacement 
 
Knee 
replacement 
 
$43,000 
 
$40,000 
 
$9,000 
 
$8,500 
 
$12,000 
 
$10,000 
 
$12,000 
 
$13,000 
 
     
 
Source: ANA-OMSS Governing Council Report B June 2007--Appendix A.  Adopted 
from York, D. (2008). Medical tourism: The trend toward outsourcing medical 
procedures to foreign countries. Journal of Continuing Education in the Health 
Professions, 28(2), 99-102. 
 
   
 According to Gould (2008), there were an estimated 47 million individuals in the 
U.S. who lacked health insurance.  As proclaimed by York (2008), "In 2007, health care 
spending was estimated at $2.2 trillion with the expectation that it will rise by 6.7% 
through 2017, twice the rate of inflation" (p. 100).  The rising cost of medical service in 
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the US has fueled a movement of Americans traveling overseas for medical treatment 
each year (York, 2008).  The low-income and middle-class Americans with limited 
finances are often unable to afford the cost of care in the U.S.  They actually travel to 
India, Thailand, or elsewhere for comparatively inexpensive health service (Gould, 
2008).  In Southeast Asia, the health sector is expanding rapidly, attributed to rapid 
growth of the private sector in coping with medical tourism (Pocock & Phua, 2011). 
A successful example is the Bumrungrad Hospital in Thailand.  In 2006, after 60 
Minutes aired its story about the hospital, Bumrungrad was bombarded with more than 
3,000 emails from the U.S. from people interested in receiving treatment there.  The 
hospital claimed to provide care for more than 435,000 international patients every year; 
58,000 of those patients were Americans (Turner, 2010).  Bumrungrad Hospital is 
famous for its (i) "rock-bottomed price" packages for medical surgery and other 
procedures; (ii) the appearance and impression of a luxury hotel; and (iii) the philosophy 
of promoting customer satisfaction.  The Bumrungrad case demonstrated that given 
enough incentives, price-conscious patients would travel in search of inexpensive health 
care (Turner, 2010). 
Medical facilities in developing countries can apply similar strategies of their low 
property values, and low wages for physicians, nurses, and other healthcare providers 
to attract price-conscious patients from overseas and create an influx of foreign patients 
to help pay for the cost of their PET service. 
Factor #4 - The buildup of reputation.  Take the successful case mentioned 
above in factor #3 of the Bumrungrad Hospital in Thailand as an example.  It took 
Bumrungrad Hospital about 10 years, from 1997 to 2006, to achieve an international 
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recognition through a sound and consistent corporate philosophy combined with the 
support of government policy (Turner, 2010).  According to Pocock and Phua (2011), 
Thailand's medical hub policy was begun in 2003 by the Thailand Board of Investment, 
whilst the Ministries of Commerce and the Department of Export Promotion collaborated 
with private hospitals.   
In 2007 alone, Thailand provided medical services for as many as 1.4 million 
foreign patients, including medical tourists, general tourists, and expatriates working or 
living in Thailand or its neighboring countries (NaRanong & NaRanong, 2011).  
Consequently, the buildup of a reputation is to attract an influx of paying patients who 
can help pay for the advanced medical equipment and diagnostic methods otherwise 
unaffordable and hence unavailable to its local citizens. 
Factor #1 - Medical expertise in a regional profound disease.  The purpose 
of establishing a medical expertise in a regional profound disease is to build a 
reputation, complementing the goal of attracting more fee paying foreign patients to 
sustain the cost of advanced medical technology.  This goal can be achieved in many 
different ways.  
 First, if there is a regional profound disease readily presented in the developing 
country in which the PET technology can be utilized to address this disease, then, this 
country can directly apply the same PET development model in Hong Kong.  It could 
establish itself as an “X” disease center similar to the liver cancer center in Hong Kong. 
 Second, another approach that could be applied is to group a team of highly 
trained medical professionals in one specialty area to launch a leading medical 
expertise in the region.  This is the case illustrated by the success of the Escorts Heart 
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Institute and Research Center in Delhi and Faridabad of India.  According to York 
(2008), the Escorts Heart Institute “performs nearly 15,000 heart operations every year 
and the death rate among patients during surgery is only 0.8 percent, less than half the 
rate of most hospitals in the U.S.” (p. 100).  This sheer volume of heart operations in 
addition to the low cost of their surgeries, about one tenth of the cost compared to the 
U.S., as shown in Table 4, put the Escorts Heart Institute in a position as one of the 
leading heart centers in the world. 
 Third, take the successful case of the Bumrungrad Hospital in Thailand again as 
an example.  The Bumrungrad Hospital positioned itself as the hub of medical tourism. 
Everyone can have a health assessment done as part of their touring plan to Thailand. 
This model of a low cost health assessment center can basically be set up in any 
country.  As a matter of fact, governments in emerging markets such as Mexico, 
Philippines, and Malaysia are promoting their medical tourist industry to attract medical 
tourism (Pocock & Phua, 2011). 
 Based on the above demonstrations, all four factors of the PET development 
experience in Hong Kong are applicable to other developing countries.  The difference 
is the time required to implement those policies.  For factor #2 of the direct payment 
method, the transition can be done in a short period of time to reach the level of cost 
efficiency.  For factors #1, #3 and #4, it may take up to 10 years to achieve the desired 
effects of building up a medical expertise, attracting a significant amount of patient 
influx, and establishing a reputation for medical tourism. 
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CHAPTER 5 
SUMMARY, CONCLUSIONS, RECOMMENDATIONS 
 
Summary 
 The purpose of this research study was to (i) explore the factors contributing to 
the PET utilization development in Hong Kong; and (ii) find out if those factors are 
applicable to other developing countries. 
Question 1.  What is the clinical advantage of PET and PET-CT in the detection 
and monitoring of cancer patients compared to conventional diagnostic imaging 
modalities? 
Question 2.  How has the medical environment in Hong Kong affected PET 
utilization development? 
Question 3.  How has the socioeconomic environment in Hong Kong affected 
PET utilization development? 
 
Research Question 1 
To summarize the literature review of chapter 2 and compare to the findings in 
chapter 4, the following is the evidence showing the clinical advantage of PET and PET-
CT in the detection and monitoring of cancer patients. 
1. The principle of PET imaging technology is to detect the abnormal 
accumulation of common nutrients, such as glucose, at the molecular level because the 
metabolic rate of cancer cells is two to 10 times higher than that of normal cells 
(Peterson et al., 2009).  Those cancer cells will light up as hot spots compared to 
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surrounding normal tissues on a 3-dimensional PET image, making them the easy 
targets for disease identification. 
2. For the evaluation of response to treatment, a PET scan can show the 
effectiveness of surgery, chemotherapy, and radiotherapy in the treatment of cancer at 
a much earlier time because it measures the metabolic activities of the cancer cells. 
Cancer cells that are successfully treated will no longer be metabolically active but may 
retain the same physical size for several months (Buck et al., 2010).  
3. In the aid of radiotherapy planning, PET-based treatment planning showed a 
significantly higher patient survival rate than those treated without the use of PET. 
Therefore, 18F-FDG PET-CT is being incorporated into the treatment-planning process 
and promises to improve the ability to confidently identify regions of disease (Buck et 
al., 2010; Ford et al., 2009).  
4. Extensive meta-analysis research by Gould et al. (2003), covering 23 CT and 
32 PET studies; and Watson et al. (2007), covering patient data from 1994 to 2002; as 
well as early studies by Bury et al. (1996) and Phelps (2000) further confirmed PET is 
more sensitive and more specific than conventional diagnostic imaging for metastatic 
disease and local recurrence of cancers respectively. 
5. The emergence of PET-CT hybrid scanners in 2000 achieved high-resolution 
anatomical images accurately co-registered with functional data, and this new 
technology further increases the sensitivity and specificity of cancer imaging with PET 
modality (Townsend, 2008).  
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Based on the five major pieces of evidence stated above, it can be shown that 
there is a clear clinical advantage of PET and PET-CT in the detection of cancer and 
monitoring of cancer patients compared to conventional diagnostic imaging modalities. 
 
Research Question 2 
In order to answer the second research question, information was summarized 
about the unique medical environment in Hong Kong affecting PET utilization 
development. 
Influenced by a locally profound cancer type, liver cancer, which is one of the top 
three causes of cancer death in Hong Kong and many Asian countries, including China, 
Taiwan, Singapore, and Japan (Ho et al., 2007), it is known that 18F-FDG PET has a 40-
50% false negative rate in the detection of liver cancer at that time (Chen et al., 2004; 
Ho et al., 2003).  In order to resolve this issue, the pioneer PET facility in Hong Kong 
(HKSH) determined to tackle this weakness of liver cancer detection by PET.  After 
several years of extensive clinical trials (Chen et al., 2003; Chen et al., 2004; Chen et 
al., 2006; Ho et al., 2003), a summary research result of the dual-tracer imaging 
protocol of 11C-Acetate and 18F-FDG PET published by Ho et al. (2007) became a well- 
recognized imaging protocol by the molecular imaging community worldwide.  Indeed, 
it was highlighted as the cover article for the 2007 issue of the Journal of Nuclear 
Medicine.  As the result of this proven protocol which eliminated a blind spot in the 
cancer detection of PET, and with the collaboration with the largest liver cancer 
treatment center in the region — The Department of Surgery at Hong Kong University, 
as well as oncology specialists, HKSH is able to capture this clinical expertise and 
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establish as well as promote itself with a medical reputation in a regionally profound 
disease (liver cancer) and accommodate local patients as well as patients from abroad.  
Encouraged by the proven clinical experience of PET and PET-CT in the detection and 
monitoring of cancer patients compared to conventional diagnostic imaging modalities 
both locally (HKSH) and overseas, private entities followed through and entered into the 
field of PET imaging.  Today, there are eight PET-CT scanners which are privately 
owned out of the total of 12 PET-CT scanners in Hong Kong (Radiation Board, 
Appendix A). 
Therefore, the medical advancement of liver cancer treatment and detection 
sped up the PET development in Hong Kong, which in turn answered the second 
research question.  
 
Research Question 3 
To summarize the findings about the socioeconomic environment in Hong Kong, 
which affect PET utilization development, the following are the key findings. 
1. The direct payment culture means patients pay their medical expenses out of 
their own pocket most of the time.  By eliminating the reimbursement burden and the 
middle layer of insurance cost, PET centers in Hong Kong are able to operate in a more 
cost-effective and economically efficient way than their counterparts in Europe and the 
United States. 
2. There has been an influx of patients.  For many years, Hong Kong has been a 
medical center for overseas Chinese because of its heritage link and high medical 
standards (Hokari, 1996).  Since the signing of the Mainland and Hong Kong Closer 
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Economic Partnership Arrangement in 2003, people from China can travel to Hong 
Kong with fewer restrictions (CEPA, 2003).  
One of the obvious examples of this influx is the reverse trend of birth rate in 
Hong Kong.  According to the Hong Kong Department of Health (2010), the birth rate 
has decreased from 16.8 per 1,000 population in 1981 to 7.1 in 2002, but then 
rebounded significantly to 12.5 in 2010.  This birth rate figure indicates that 
approximately 50% of the newborn babies in Hong Kong currently are coming from 
Mainland China (Hospital Authority, 2010).  
Another source of the patient influx is the expatriates from foreign companies.  
According to Yang (2010), China approved a total of 632,298 foreign-funded enterprises 
between 1980 and 2007.  When those expatriates seek medical services, they will go 
to Hong Kong simply because they have confidence in physicians with US government 
recognized qualifications to practice in the specialties and those doctors are sufficiently 
competent in the English language to provide services to English-speaking clients (US 
Consulate Hong Kong, 2011). 
Although there are no official or direct statistics showing how many Mainland 
China patients and expatriates seek medical services in Hong Kong annually, given the 
population of 1.3 billion in China (World Bank), and the example of the reversed birth 
rate, a very small fraction of an influx from China will show a tremendous impact in the 
medical system in Hong Kong. 
Therefore, the third research question of the socioeconomic environment in Hong 
Kong and its effect on PET utilization development is answered by two things:  the 
direct payment culture and the influx of patients.  The direct payment culture enables 
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the PET centers to operate in a more cost-effective and economically efficient way, and 
the influx of patients from Mainland China and other overseas Chinese as well as 
expatriates provides extra sources of financial support to the viability of PET facilities.  
 
Summary of Findings 
As mentioned in previous paragraphs, the key factors that have contributed to a 
higher ratio of PET-CT scanners in Hong Kong are the following: 
1) medical expertise in a regionally profound disease 
2) the direct payment culture which enables an economically efficient and a cost-
effective operation 
3) the influx of patients from neighboring countries 
4) the reputation of its medical services  
For factor #1 — establishing a medical expertise in a regionally profound 
disease, the purpose of this is to build a reputation and can be achieved in at least two 
ways. 
First, if there is a regionally profound disease readily presented in the developing 
country in which the PET technology can be utilized to address this disease, then this 
country can directly apply the same PET utilization development model as Hong Kong.  
That country could establish itself as an “X” disease center similar to the liver cancer 
center in Hong Kong. 
Second, another approach that can be applied is to become a leading medical 
expertise in the region such as the successful case of the heart center of the Escorts 
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Heart Institute and Research Center in Delhi and Faridabad of India, as mentioned in 
Chapter 4. 
For factor #2 — the direct payment method which enables a cost-effective 
operation.  The direct payment method can be readily applied to other developing 
countries if those countries wish to do so in order to boost an economically efficient and 
a cost-effective operation.  
For factor #3 — the influx of patients from neighboring countries.  The goal is to 
create an influx of paying patients from other countries to supplement the local medical 
demand.   
For factor #4 — the buildup of a reputation of medical services.  As factors #1 
and # 4 can be closely related and complementary to each other, the main goal of 
building up a reputation is the same, which is to attract an influx of paying patients who 
can help pay for the advanced medical equipment and diagnostic methods otherwise 
unaffordable and possibly unavailable to its local citizens. 
Based on the above demonstrations, all four factors of the PET development 
experience in Hong Kong are applicable to other developing countries.  The difference 
is the time required to implement those policies.  For factor #2 of direct payment 
method, the transition can be done in a short period of time to reach the level of cost 
efficiency.  Nevertheless, factors #1, #3 and #4 may take up to 10 years to achieve the 
desired effects of building up a medical expertise, attracting a significant patient influx, 
and establishing a reputation for medical tourism. 
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Conclusions 
According to the findings in Chapter 4, the cost figures in Table 6 (page 43) show 
that the average cost level is about 13.4% for India (the arithmetic mean of 5.6% and 
21.2%), 17.1% for Thailand (the arithmetic mean of 6.3% and 27.9%), and 20.2% for 
Singapore (the arithmetic mean of 7.8% and 32.5%), compared to the cost in the U.S.  
In a similar manner, the result from this study also showed that cost effectiveness is the 
most significant factor which has enabled Hong Kong, a developing region with about 
half the economic strength of Germany, to sustain a higher ratio of PET-CT scanners.  
Buoyed by this direct payment culture which has the equivalence of 100% 
reimbursement rate and the elimination of the entire middle layer of insurance cost, 
billing coding hurdles, and reimbursement burden as well as bad debt, PET centers in 
Hong Kong are able to operate in a more cost-effective and economically efficient way 
than their counterparts in Europe and the United States.  In addition, the reputation of a 
medical expertise in a regionally profound disease—liver cancer, the influx of patients 
from Mainland China, overseas Chinese as well as expatriates, and the international 
accredited status of its medical services also play their complementary roles in 
contributing to the higher ratio of PET technology.  
In The World Is Flat, author Friedman (2005) suggested that most of us have no 
idea of the breadth of economic globalization as it exists today.  While people think of 
globalization in terms of manufacturing and some segments of service industries, a 
surprise movement in outsourcing is medical service. 
Applying the same direct payment method, developing countries with a low cost 
environment are able to set up and operate a PET facility with a much smaller overhead 
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than their counterparts in the U.S. or Germany, making the latest medical technology 
assessable to their citizens, which will have a noteworthy health benefit to their 
countries. 
 
Recommendations 
Based on the findings of this study, the majority of PET service providers in Hong 
Kong are from the private sector and they outnumber those in the public sector by a two 
to one ratio.  The following recommendations are offered in two directions.  The first 
set of recommendations is for the implementation of PET technology in developing 
countries; and the second set of recommendations is for researchers who want to adopt 
a quantitative approach to this topic in the future. 
 
Recommendations for the Implementation of PET Technology in Developing 
Countries 
1. The implementation of advanced PET technology in developing countries 
should be led by the private sector because private organizations are more efficient in 
terms of maximizing the cost effectiveness and flexibilities in a competitive marketplace 
compared to public organizations.  This will increase the successful chance of 
achieving a financially self-sustainable PET facility.  
2. Contributions from both public resources and philanthropic foundations should 
be sought to pay for the initial setup cost associated with a new PET facility because the 
financial burden is the major hurdle preventing the utilization of this advanced 
technology.  Forms of contribution can include pieces of land, building materials, 
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interior furnishings, medical equipment, direct monetary funding, etc.  This will greatly 
reduce the debt level and improve the viability of the new facility.  
 
Recommendations for Researchers  
Private PET centers in Hong Kong are more or less competitors among themselves in 
the market of medical services.  Sensitive patient and operational data such as patient 
demographics which will enable a quantitative analysis to study the financial impact of 
the influx of patients are guarded as business secrets.  The following recommendations 
are offered to researchers who want to adopt a quantitative approach to this topic in the 
future. 
1. Spend more time convincing the practitioners of these private PET facilities 
that the confidentiality of their patient and operational data will be maintained. 
2. Ask permission to collect patient data on site without the expenses of 
additional resources from these private facilities. 
3. Seek approval from the public hospitals to conduct patient data survey to 
complete the whole picture of PET Services in Hong Kong.  
4. Keep in mind the sensitivity and the feelings of patients and their relatives 
while collecting demographic data because cancer is a devastating disease to 
most of the people.   
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Appendix A 
 
Radiation Board Correspondences 
 
 
 
 
 
Email dated October 16, 2011. 
 
 
 
 
Dear Steve, 
 
Thank you very much for your message dated 11 Oct 2011 below. 
 
I would like to provide the information as follows: 
 
1.    How many PET scanners are operational in Hong Kong in year 2011? According 
to our licensing records, there are currently 11 PET scanners in HK. 
 
2.    How many of those PET scanners are from private sector? 8 of them are from 
private sector. 
 
3.    When was the established year of operation of the first three PET centers in Hong 
Kong? The first 3 PET centres were established in 1998, 2001 and 2003. 
 
4.    When was the established year of operation of the first PET center in public 
hospital (QMH)?2003 (QEH)  
 
Thank you very much for your attention. 
 
Best regards 
Joseph Mok 
Radiation Board  
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Email dated October 18, 2011. 
 
 
Dear Steve, 
 
Yes, we have not include the PYNEH as the centre is not commenced operation. 
 
For Q3, your sequence is correct but I have to correct that the year should be 1998, 
2001, 2002. 
 
Thank you very much for your attention. 
 
Best regards 
Joseph 
 
 
Steve Sitt <stevesitt@siu.edu> 
17/10/2011 23:53 
 
         
        To:       p3_rhu@dh.gov.hk 
        cc:        
        Subject:       Re: Fw: PET Survey Request 
                
 
Good morning Joseph, 
What a pleasant surprise to receive a response from you! Thank you very much for your 
detailed information. Please thank Dr. Cheng for giving permission to use these data 
and let you, one of the most experienced and resourceful persons from the Radiation 
Board of the Department of Health in Hong Kong, handle this case. 
 
For question #1, apart from the existing operations, there were two private PET centers 
ran out of business during the last few years, one located in Causeway Bay (Hercules) 
and another in Central. Those business events made the number of total scanners 
fluctuate in the last 10 years. Therefore, these data needs to be updated often. 
 
The following demographic data shows a total of 12 PET scanners because I counted 
the one under installation at PYNEH. Is this the source of our total number discrepancy? 
Please advice. 
 
NT: 
PWH   1 PET-CT 
Union  1 PET-CT 
 
  
Kowloon: 
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Baptist  1 PET-CT 
St Teresa  1 PET-CT 
Evangel  1 PET-CT 
QEH   1 PET-CT 
油麻地  1PET-CT  (HK Healthcheck Company Limited) 
 
HK: 
HKSH  2 PET-CT 
Adventist  1 PET-CT 
QMH   1 PET-CT 
PYNEH  1 PET-CT (under installation) 
 
For question #3, the order of the 1st, 2nd,and 3rd PET center is HKSH, St Teresa and 
HK Adventist. Pleaseconfirm the validity of my sequence. 
 
Thank you very much for your attention and have a good day.  
 
Steve 
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Appendix B 
 
Medical Claim Forms from Major Insurance Providers in Hong Kong 
(In alphabetical order) 
 
 
 
American International Assurance Company (Bermuda) Limited 
Bank of China Group Insurance Company Limited 
Bupa 
CIGNA Worldwide Life Insurance Company Limited 
HSBC Insurance 
Hong Leong Insurance (Asia) Ltd. 
ING General Insurance International 
Manulife Individual Insurance 
Sompo Japan Insurance (Hong Kong) Co., Ltd. 
  
73 
 
 
 
American International Assurance Company (Bermuda) Limited  
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Bank of China Group Insurance Company Limited  
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Bupa 
 
 
 
77 
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CIGNA Worldwide Life Insurance Company Limited 
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HSBC Insurance 
 
 
81 
 
 
 
 
 
82 
 
 
 
Hong Leong Insurance (Asia) Ltd. 
 
 
83 
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ING General Insurance International 
 
 
85 
 
 
 
 
 
86 
 
 
 
Manulife Individual Insurance 
 
 
87 
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Sompo Japan Insurance (Hong Kong) Co., Ltd. 
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